Home

World-leading research advancing drug discovery, drug delivery and global health.

 

Our impact

Our vision is to be an international leader in drug discovery and development with impact in the treatment of major global health burdens.

Collaborators and industry partners

Drug discovery and the optimised use of medicines is complex and multidisciplinary. Collaboration is vital and our collaborators and industrial partners are a critical part of our mission.

Our drug discovery activities

We are a world leader in drug discovery, development and innovation with programs directed to diseases such as COVID-19, malaria, mental health, cardiovascular disease, diabetes and maternal health.

Find a researcher

Want to discover more about our researchers? Search their profiles here by field of research or keyword.

Research seminars

If you are interested in the discovery, development and use of new medicines click here to see a list of upcoming seminars/events.

Our research platforms

We operate a range of research facilities directed towards translational drug discovery.

Positions available Access available post-doctoral, ECR & faculty positions. Find your next role.
Have Questions? Get in touch with us Contact Us.

Browse our latest news

CREATE medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license agreement with Monash University

CREATE and MIPS will jointly advance targeted Chimeric Antigen Receptor (CAR) therapy, with the goal of enabling precise, cell-type-specific in vivo delivery of CAR payloads.
1 August, 2026 Research

Monash and partners to build new lab to fast-track drug invention, trials and commercialisation

HTX could allow Monash to screen a library of ~1,000 compounds automatically in three days without human intervention, which is well beyond what is currently feasible with manual data collection.
22 July, 2026 Research

Monash University joins TGA Academic Outreach Program

Combining Monash’s research expertise with the TGA’s regulatory leadership, we can advance innovation while also creating meaningful opportunities for student engagement and exposure to real-world regulatory challenges
16 July, 2026 Research

Monash study proves world-leading safety and peace of mind in voluntary assisted dying

Victorian model for oral self-administration of voluntary assisted dying (VAD) medication is safe and effective, providing the largest global experience of patient outcomes.
10 July, 2026 Research

New national program targeting harmful and unnecessary medicine use in Australia

SUPPORT-Meds aims to bridge the gap between existing evidence-based guidelines and everyday clinical practice by providing practical, evidence-based resources.
1 July, 2026 Medicine & health

New research makes critical discovery for the global fight against antibiotic resistance

MIPS researchers used a validated laboratory infection system to expose bacterial samples from infected patients to simulated antibiotic dosing regimens, as would actually occur in hospitalised patients.
25 June, 2026 Research
Dr Amanda Cross

New Guiding Principles to improve incontinence medication safety for people living with dementia

Monash University researchers are today launching the first co-designed resources to safely guide the use of urinary incontinence medications for people living with dementia.
16 June, 2026 Research

Copper drug restores memory and clears toxic Alzheimer’s proteins

MIPS researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer’s proteins and improves long-term spatial memory.
12 June, 2026 Research

Monash University calls for public input on first dementia guidelines update in a decade

Monash University is calling on healthcare professionals and the broader community to help shape the future of dementia care, opening public consultation on the first major draft update to the national clinical guidelines.
11 May, 2026 Research